Structure Therapeutics Inc. (GPCR)
USD 15.76
(4.68%)
USD 15.76
(4.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -79.41 Million | -46.12 Million | -32.16 Thousand | -14.28 Thousand |
| Net Income | -89.54 Million | -51.32 Million | -38.04 Thousand | -15.87 Thousand |
| Depreciation & Amortization | 949.17 Thousand | 277 Thousand | 72.00 | 20.03 Thousand |
| Deferred income taxes | 860 Thousand | - | 27.00 | -20.03 Thousand |
| Stock-based compensation | 8.19 Million | 2.51 Million | 1.48 Million | 570 Thousand |
| Change in working capital | 6.95 Million | 2.96 Million | 4062.00 | 946.00 |
| Other non-cash items | -6.83 Million | -558 Thousand | 241.00 | 77.00 |
| Investing Cash Flow | -268.1 Million | -62.1 Million | 17.85 Thousand | -21.14 Thousand |
| Investments in PPE | -2.16 Million | -155 Thousand | -1206.00 | -19.00 |
| Acquisitions | 266.17 Thousand | 61.95 Thousand | -19.06 Thousand | - |
| Investment purchases | -416.99 Million | -123.45 Million | -4212.00 | -21.12 Thousand |
| Sales/Maturities of investments | 151.04 Million | 61.5 Million | 23.27 Thousand | - |
| Other Investing Activities | -266.17 Thousand | -61.95 Thousand | 19.06 Thousand | -21.12 Thousand |
| Financing Cash Flow | 451.13 Million | 29.01 Million | 103.25 Thousand | 25.83 Thousand |
| Debt repayment | - | - | - | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | -5992.87 | - | - |
| Common Stock Issuance | 472.68 Million | 31.49 Million | 103.39 Million | 25.88 Million |
| Other Financing Activities | -21.54 Million | -2.47 Million | -103.28 Million | -25.85 Million |
| Accounts receivables | - | - | - | - |
| Accounts payables | -859.25 Thousand | 2.15 Million | 1897.00 | 1020.00 |
| Inventory | - | - | - | - |
| Other working capital | 7.81 Million | 815 Thousand | 2165.00 | -74.00 |
| Cash at beginning of period | 26.09 Million | 105.3 Million | 16.35 Thousand | 25.94 Thousand |
| Cash at end of period | 129.79 Million | 26.09 Million | 105.3 Thousand | 16.35 Thousand |
| Capital Expenditure | -2.16 Million | -155 Thousand | -1206.00 | -19.00 |
| Effect of forex changes on cash | 90.14 Thousand | - | - | - |
| Net cash flow / Change in cash | 103.7 Million | -79.21 Million | 88.95 Thousand | -9593.00 |
| Free Cash Flow | -81.58 Million | -46.27 Million | -33.36 Thousand | -14.3 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -26 Million | -25.99 Million | -89.54 Million | -24.67 Million | -23.86 Million | -23.28 Million |
| Depreciation & Amortization | 231.73 Thousand | 658.92 Thousand | 949.17 Thousand | 280.91 Thousand | 79 Thousand | 74 Thousand |
| Deferred income taxes | - | - | 860 Thousand | -1.27 Million | -1.66 Million | -1.64 Million |
| Stock-based compensation | 4.19 Million | 2.74 Million | 8.19 Million | 2.09 Million | 1.85 Million | 1.7 Million |
| Change in working capital | -2.03 Million | -8.15 Million | 6.95 Million | 2.73 Million | 2.75 Million | 6.16 Million |
| Other non-cash items | 6.28 Million | -1.03 Million | -6.83 Million | -1.07 Million | 276 Thousand | 88 Thousand |
| Investing Cash Flow | -204.23 Million | 1.41 Million | -268.1 Million | -180.88 Million | 30.12 Million | -68.71 Million |
| Investments in PPE | -426.47 Thousand | -161.73 Thousand | -2.16 Million | -1.15 Million | -820 Thousand | -191 Thousand |
| Acquisitions | - | - | 266.17 Thousand | -37.57 Thousand | -30.94 Thousand | 68.52 Thousand |
| Investment purchases | -283.21 Million | -31.86 Million | -416.99 Million | -237 Million | -14.93 Million | 24.26 Million |
| Sales/Maturities of investments | 79.4 Million | 33.44 Million | 151.04 Million | 57.27 Million | 45.88 Million | -92.78 Million |
| Other Investing Activities | -204.08 Thousand | 1580.00 | -266.17 Thousand | -1.00 | 30.94 Thousand | -68.52 Thousand |
| Financing Cash Flow | 514.01 Million | 700.85 Thousand | 451.13 Million | 281.97 Million | 473 Thousand | -297 Thousand |
| Debt repayment | - | - | - | -371.72 Thousand | -185.86 Thousand | -94.04 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 514.59 Million | 753.77 Thousand | 472.68 Million | 300.45 Million | 775.82 Thousand | -534.05 Thousand |
| Other Financing Activities | -588.22 Thousand | -52.91 Thousand | -21.54 Million | -18.48 Million | -116.96 Thousand | 331.09 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -4.38 Million | 1.81 Million | -859.25 Thousand | 1.38 Million | -2.38 Million | 1.04 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.35 Million | -9.97 Million | 7.81 Million | 1.34 Million | 5.13 Million | 5.12 Million |
| Cash at beginning of period | 97.83 Million | 129.79 Million | 26.09 Million | 50.63 Million | 40.59 Million | 126.49 Million |
| Cash at end of period | 381.63 Million | 97.83 Million | 129.79 Million | 129.79 Million | 50.63 Million | 40.59 Million |
| Capital Expenditure | -426.47 Thousand | -161.73 Thousand | -2.16 Million | -1.15 Million | -820 Thousand | -191 Thousand |
| Effect of forex changes on cash | - | - | 90.14 Thousand | -15.69 Thousand | - | - |
| Net cash flow / Change in cash | 283.8 Million | -31.96 Million | 103.7 Million | 79.15 Million | 10.04 Million | -85.9 Million |
| Free Cash Flow | -26.79 Million | -34.18 Million | -81.58 Million | -23.06 Million | -21.37 Million | -17.08 Million |
1842
MISVF
LINRF
TTNM
RAD
CEN